Antibodies—proteins that are produced by our immune system to protect us—are crucial for recognizing and getting rid of unwanted substances, or antigens, in our body. Although their role is universal, ...
SAN DIEGO--(BUSINESS WIRE)--AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager ...
IGM Biosciences is developing antibodies that are different from most monoclonal antibodies currently in use. They have two main pipeline projects focused on cancer and rheumatologic disease. The ...
MOUNTAIN VIEW, Calif., Dec. 11, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing IgM antibodies, today announced ...
Phase II trial of docetaxel and carboplatin in patients with newly diagnosed, extensive-stage, small cell carcinoma of the lung (SCLC) No significant financial relationships to disclose. This is an ...
As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses ...
Sanofi will pay IGM Biosciences $150 million and potentially billions more in milestone payments as part of a deal to develop agonist antibodies for cancer and inflammatory diseases. The well-known ...
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results